TCERG1(转录延伸调节因子1,英文全称Transcription Elongation Regulator 1)是一个参与转录延伸调控的基因,其编码的蛋白质在RNA聚合酶II介导的转录延伸过程中发挥重要作用。该蛋白通过与其他转录延伸因子(如DSIF和NELF复合物)相互作用,调节RNA聚合酶II在基因转录中的暂停和释放,从而影响基因表达的效率和准确性。TCERG1的生物学功能主要体现在维持转录过程的动态平衡,确保mRNA合成的正确性和完整性。其主要作用位点是细胞核,特别是在转录活跃的染色质区域。TCERG1的突变可能导致转录延伸异常,进而影响下游基因的表达,可能引发发育缺陷或疾病。研究表明,TCERG1与某些神经退行性疾病(如亨廷顿病)和癌症有关,其异常表达可能通过扰乱转录调控网络促进疾病进展。如果TCERG1过表达,可能增强某些致癌基因的转录,导致细胞增殖失控;而降低表达则可能影响关键基因的正常转录,引发细胞功能障碍。TCERG1属于转录延伸因子相关基因家族,该家族成员通常具有调控RNA聚合酶II活性的功能,并在转录后修饰和mRNA加工中发挥作用。基因家族的共性包括参与转录延伸、暂停和终止的调控,以及与染色质重塑因子的协同作用。目前关于TCERG1的研究仍在深入,其在疾病中的具体机制和潜在治疗靶点值得进一步探索。
This gene encodes a nuclear protein that regulates transcriptional elongation and pre-mRNA splicing. The encoded protein interacts with the hyperphosphorylated C-terminal domain of RNA polymerase II via multiple FF domains, and with the pre-mRNA splicing factor SF1 via a WW domain. Alternative splicing results in multiple transcripts variants encoding different isoforms. [provided by RefSeq, Jul 2008]
Subcellular localization of TCERG1 (and its protein):
Gene Ontology (GO) terms for TCERG1:
| Interacting Gene | Interaction | Source/Score |
| Disease | Score | NofPmids | NofSnps | Source |
| Huntington Disease | 0.00272435 | 1 | 0 | LHGDN |
| Celiac Disease | 0.002367032 | 1 | 0 | GAD |
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com